Cardiovascular role of urotensin II: effect of chronic infusion in the rat

被引:36
|
作者
Kompa, AR
Thomas, WG
See, F
Tzanidis, A
Hannan, RD
Krum, H
机构
[1] Monash Univ, Alfred Hosp, NHMRC Ctr Lin Res Excellence Therapeut, Dept Med, Melbourne, Vic 3181, Australia
[2] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Cent & Eastern Clin Sch, Melbourne, Vic 3181, Australia
[3] Alfred Hosp, Baker Med Res Inst, Prahran, Vic 3181, Australia
关键词
urotensin II; vasoconstrictor peptide; extracellular matrix; hemodynamics; ventricular function; heart failure;
D O I
10.1016/j.peptides.2004.03.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin II (UII) is a potent vaso-active peptide thought to have multiple roles in the regulation of cardiovascular physiology and pathophysiology. The actions of UII are complex and difficult to interpret given its systemic hemodynamic effects and variable action on different vascular beds and isolated vessels. Direct effects of UII on the myocardium, include myocyte hypertrophy, extracellular matrix deposition and contractility. These observations, together with elevated plasma levels found in disease, are common traits reported in other pathophysiologically implicated neurohormonal systems. In this review, we include original data obtained from chronic infusion of UII in rats. We report a reduction in first derivative of left ventricular pressure (+dP/dt), as well as an increase in the ratio of left ventricular collagen I:III, that may contribute to the reduced myocardial contractility observed in these animals. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1783 / 1788
页数:6
相关论文
共 50 条
  • [1] Role of urotensin II in atherosclerotic cardiovascular diseases
    Pakala, Rajbabu
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2008, 9 (03) : 166 - 178
  • [2] Novel insights into the role of urotensin II in cardiovascular disease
    Pereira-Castro, Joao
    Bras-Silva, Carmen
    Fontes-Sousa, Ana Patricia
    DRUG DISCOVERY TODAY, 2019, 24 (11) : 2170 - 2180
  • [3] The role of urotensin II in cardiovascular and renal physiology and diseases
    Zhu, Yi-Chun
    Zhu, Yi-Zhun
    Moore, Philip Keith
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 884 - 901
  • [4] Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium
    Yonggang Zhang
    Juxiang Li
    Jun Cao
    Jingjiong Chen
    J. Yang
    Zhaokang Zhang
    Junbao Du
    Chaoshu Tang
    Heart and Vessels, 2002, 16 : 64 - 68
  • [5] Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium
    Zhang, YG
    Li, JX
    Cao, J
    Chen, JJ
    Yang, J
    Zhang, ZK
    Du, JB
    Tang, CS
    HEART AND VESSELS, 2002, 16 (02) : 64 - 68
  • [6] EFFECT OF CHRONIC INTRACEREBROVENTRICULAR INFUSION OF ANGIOTENSIN-II IN RAT
    BAN, D
    MOFFITT, B
    MCDONALD, WJ
    AUMANN, S
    PORTER, GA
    CLINICAL RESEARCH, 1978, 26 (02): : A153 - A153
  • [7] Urotensin II in cardiovascular regulation
    Russell, Fraser D.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) : 775 - 785
  • [8] Urotensin II in the cardiovascular system
    Richards, AM
    Charles, C
    PEPTIDES, 2004, 25 (10) : 1795 - 1802
  • [9] Urotensin II and cardiovascular diseases
    Thanassoulis, G
    Huyhn, T
    Giaid, A
    PEPTIDES, 2004, 25 (10) : 1789 - 1794
  • [10] Effect of human urotensin-II infusion on hemodynamics and cardiac function
    Hassan, G
    Chouiali, F
    Saito, T
    Hu, F
    Douglas, S
    Ao, ZH
    Willette, R
    Ohlstein, E
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 125 - 128